ANDA 75504, held by Ani Pharms. Quinapril Hydrochloride.
As of Nov 16, 2026, ANDA 75504 (Quinapril Hydrochloride), held by Ani Pharms, was first approved by FDA on Aug 24, 2007, with 1 approved supplement and 0 published complete response letters.
| Date | Submission | Status | Documents |
|---|---|---|---|
| Aug 24, 2007 | Original application | Approved |
| Quinapril HydrochlorideEQ 5MG BASE · tablet;oral | Quinapril Hydrochloride | Discontinued |
| Quinapril HydrochlorideEQ 10MG BASE · tablet;oral | Quinapril Hydrochloride | Discontinued |
| Quinapril HydrochlorideEQ 20MG BASE · tablet;oral | Quinapril Hydrochloride | Discontinued |
| Quinapril HydrochlorideEQ 40MG BASE · tablet;oral | Quinapril Hydrochloride | Discontinued |
| Jan 28, 2010 | Supplement 3Labeling | Approved | None posted |
| Aug 24, 2007 | Original application | Approved |
Approvals, supplements, products and documents come from FDA's Drugs@FDA data files, refreshed daily; Drugs@FDA lists approved applications only. Complete response letters are FDA's published letters. Drugs@FDA and FDA complete response letters